Scancell Holdings PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP1.53 |
Market Cap |
GBP27.73 M |
Shares Outstanding |
465.36 M |
Public Float |
361.91 M |
Address |
John Eccles House Oxford Oxfordshire OX4 4GP United Kingdom |
Employees | - |
Website | http://scancell.co.uk |
Updated | 07/08/2019 |
Scancell Holdings Plc engages in the development of novel therapeutic vaccines for the treatment of cancer. It operates through ImmunoBody and Moditope technology platforms. The company was founded by Lindy Gillian Durrant in 1997 and is headquartered in Oxford, the United Kingdom. |